(Q79529692)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17213801%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

title

A gene transcription signature of the Akt/mTOR pathway in clinical breast tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17213801%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

Creighton CJ

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17213801%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

8 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17213801%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17213801%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17213801%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

page(s)

4648-4655

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17213801%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

issue

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17213801%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210245

24 December 2019

exact match

0 references

cites work

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

The Akt pathway in human breast cancer: a tissue-array-based analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Genes regulated by estrogen in breast tumor cells in vitro are similarly regulated in vivo in tumor xenografts and human breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Cluster analysis and display of genome-wide expression patterns

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Clinical efforts to combine endocrine agents with targeted therapies against epidermal growth factor receptor/human epidermal growth factor receptor 2 and mammalian target of rapamycin in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

AKT activation predicts outcome in breast cancer patients treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

PI3K/Akt/mTOR pathway as a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Java Treeview--extensible visualization of microarray data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Ras, PI(3)K and mTOR signalling controls tumour cell growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Discovering statistically significant pathways in expression profiling studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210245

7 January 2021